PH
Therapeutic Areas
RDP Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PromptDegrader™ Platform | Platform for IDR-protein driven diseases | Pre-clinical |
| E7 Degrader | HPV-driven cancers (e.g., cervical) | Pre-clinical |
| MYC Degrader | MYC-driven cancers | Pre-clinical |
| CROMOC | Next-generation Drug Delivery Module | Discovery/Pre-clinical |
| CP201 | Cancer (oral alkyl ether lipid) | Discovery/Pre-clinical |